STAT Plus: Will the ‘patent dance’ cause Amgen to temporarily pull a biosimilar off the market?
"Anything that has the potential to keep a biosimilar off the market longer necessarily has a cost implication," said patent attorney Alexandra Valenti.
News Ticker
- [ November 30, 2022 ] Postdoctoral Fellow – CAR T Cell Therapy – City of Hope – Duarte, CA Los Angeles Biotech Jobs
- [ November 30, 2022 ] Research Associate I – Cancer and Stem Cell Biology – City of Hope – Duarte, CA Los Angeles Biotech Jobs
- [ November 30, 2022 ] Arcadia Biosciences (RKDA) Announces CFO Transition Los Angeles Biotech News
- [ November 30, 2022 ] Security Officer – Biotech Company – Allied Universal® – Oceanside, CA Los Angeles Biotech Jobs
- [ November 30, 2022 ] SkillsetGroup CEO in Inc. Magazine: Keep Your Employee; Give them a Path Los Angeles Biotech News
Copyright © 2021 Biotech Networks, LLC
